U.S. Joins Pfizer Suit Over Drug’s Marketing
Tuesday, September 21, 2010 - 20:35
in Psychology & Sociology
The drug maker and its Wyeth unit are accused by two whistle-blowers of illegal off-label marketing of a drug used to prevent rejection of kidney transplants.